The home-based care M&A landscape has been very active over the last year. And as long as the publicly traded companies remain in good standing, investment activity from private equity players and others is likely to remain strong, Home Health Care News reports.
That’s according to Mertz Taggart Managing Partner Cory Mertz, who said that even if the number of transactions ticks down in 2022, interest and demand is likely to hold steady. Read more.
